Hims & Hers Health, Inc. Class Action Lawsuit Deadline

Strategic Insights -

Investors who purchased Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025, and June 23, 2025, inclusive, have until August 25, 2025, to file a lead plaintiff motion in the class action lawsuit. The lawsuit alleges that Hims made false and misleading statements about its business, operations, and prospects during this time period. On June 23, 2025, Novo Nordisk announced that it was terminating its partnership with Hims due to the company's deceptive promotion and selling of illegitimate, knockoff versions of Wegovy. As a result, Hims' share price fell $22.24, or 34.6%, to close at $41.98 per share on June 23, 2025.

Key Takeaways:

  • Hims & Hers Health, Inc. (NYSE: HIMS) is the subject of a class action lawsuit due to alleged false and misleading statements made by the company during the Class Period.
  • The lawsuit claims that Hims engaged in the deceptive promotion and selling of illegitimate, knockoff versions of Wegovy, which put patient safety at risk and resulted in the termination of its partnership with Novo Nordisk.
  • Investors who purchased Hims securities between April 29, 2025, and June 23, 2025, may be eligible to participate in the class action lawsuit.
  • The lead plaintiff motion deadline is August 25, 2025.
  • The complaint alleges that defendants failed to disclose material adverse facts about the company's business, operations, and prospects during the Class Period.
  • Hims' share price fell $22.24, or 34.6%, to close at $41.98 per share on June 23, 2025, after Novo Nordisk announced the termination of their partnership.
  • The alleged false and misleading statements were made by Hims' defendants throughout the Class Period.
  • The class action lawsuit seeks to recover damages on behalf of investors who purchased Hims securities during the Class Period.

Statistics:

  • 34.6%: The percentage decline in Hims' share price on June 23, 2025, after Novo Nordisk announced the termination of their partnership.
  • $22.24: The dollar amount by which Hims' share price fell on June 23, 2025.
  • April 29, 2025: The start date of the Class Period.
  • June 23, 2025: The end date of the Class Period.
  • August 25, 2025: The deadline to file a lead plaintiff motion in the class action lawsuit.

Sources:

  • "Hims & Hers Health, Inc. (HIMS) to Announce Results for Second Quarter 2025" (GLOBE NEWSWIRE, July 07, 2025)
  • "Novo Nordisk Terminates Partnership with Hims & Hers Health, Inc. due to Deceptive Promotion and Selling of Illegitimate, Knockoff Versions of Wegovy" (PR Newswire, June 23, 2025)